Schmieden, Germany

Doris Huebler



Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Work of Doris Huebler in Testosterone Delivery Systems

Introduction

Doris Huebler, an accomplished inventor based in Schmieden, Germany, has made significant strides in the field of pharmaceutical sciences. With a focus on developing innovative drug delivery systems, her research contributes to enhancing the quality of life for individuals with hormone deficiencies, particularly among the elderly.

Latest Patents

Huebler holds a patent for a groundbreaking bioadhesive tablet containing testosterone and testosterone ester mixtures. This invention introduces a method for creating a tablet that effectively controls testosterone blood levels, which is especially beneficial for elderly men experiencing partial androgen deficiency. The patent outlines a process that includes spray-drying an alcoholic solution or suspension mixed with organic polymers to yield a bioadhesive tablet. This tablet is designed to be buccally administered, providing a predestined release profile that aligns with the circadian rhythm, allowing for improved testosterone management.

Career Highlights

Doris Huebler has established herself as a vital member of Jenapharm GmbH & Co. KG, where her innovative spirit drives forward-thinking approaches in medication development. Her commitment to enhancing pharmaceutical formulations has garnered recognition in the field, especially with her focus on treating hormone deficiencies effectively.

Collaborations

Throughout her career, Huebler has collaborated with esteemed colleagues, including Guenter Kaufmann and Michael Oettel. These partnerships have enabled her to expand research efforts and translate theoretical concepts into practical applications within the pharmaceutical industry.

Conclusion

Doris Huebler's contributions to the field of testosterone delivery systems exemplify the impact that innovative inventions can have on patient care. Her patent for a bioadhesive tablet is a testament to her dedication to improving treatment options for those in need. As research continues to evolve, Huebler's work remains a crucial step towards advanced therapeutic strategies in hormone management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…